Eijiro Jimi

13.1k total citations · 3 hit papers
138 papers, 10.6k citations indexed

About

Eijiro Jimi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eijiro Jimi has authored 138 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 60 papers in Oncology and 49 papers in Cancer Research. Recurrent topics in Eijiro Jimi's work include Bone Metabolism and Diseases (81 papers), Bone health and treatments (54 papers) and NF-κB Signaling Pathways (46 papers). Eijiro Jimi is often cited by papers focused on Bone Metabolism and Diseases (81 papers), Bone health and treatments (54 papers) and NF-κB Signaling Pathways (46 papers). Eijiro Jimi collaborates with scholars based in Japan, United States and Germany. Eijiro Jimi's co-authors include Naoyuki Takahashi, Nobuyuki Udagawa, Sankar Ghosh, T. John Martin, Matthew T. Gillespie, Ichiro Nakamura, Tatsuo Suda, Tatsuo Suda, Michael J. May and Haihong Zhong and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Eijiro Jimi

134 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

1999 1.8k citations Naoyuki Takahashi, Nobuyuki Udagawa et al. profile →
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction

2000 1.1k citations Naoyuki Takahashi, Eijiro Jimi et al. profile →
The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1

2002 803 citations Haihong Zhong, Michael J. May et al. Molecular Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eijiro Jimi Japan	46	7.6k	4.5k	2.7k	1.9k	1.5k	138	10.6k
Hiroshi Takayanagi Japan	34	7.8k 1.0×	4.4k 1.0×	2.1k 0.8×	2.4k 1.3×	1.6k 1.1×	58	10.9k
Tomoki Nakashima Japan	47	7.0k 0.9×	3.9k 0.9×	1.7k 0.6×	2.4k 1.3×	1.7k 1.1×	133	11.4k
Lianping Xing United States	61	8.6k 1.1×	5.3k 1.2×	2.5k 0.9×	1.8k 0.9×	2.2k 1.5×	177	14.2k
Nacksung Kim South Korea	46	6.6k 0.9×	3.7k 0.8×	1.7k 0.6×	2.0k 1.0×	952 0.6×	121	9.2k
Matthew T. Gillespie Australia	60	9.6k 1.3×	6.6k 1.5×	1.6k 0.6×	2.3k 1.2×	2.2k 1.5×	156	14.3k
Hisataka Yasuda Japan	49	11.1k 1.5×	7.7k 1.7×	2.4k 0.9×	1.7k 0.9×	2.1k 1.4×	118	14.7k
G. David Roodman United States	63	7.1k 0.9×	7.2k 1.6×	1.4k 0.5×	1.4k 0.7×	1.6k 1.1×	198	13.0k
Maxine Gowen United States	55	5.6k 0.7×	3.3k 0.7×	1.3k 0.5×	1.2k 0.6×	2.3k 1.5×	122	10.0k
Masaaki Goto Japan	34	6.1k 0.8×	4.3k 1.0×	1.3k 0.5×	764 0.4×	1.2k 0.8×	138	9.3k
Jean‐Marie Delaissé Denmark	55	5.4k 0.7×	4.0k 0.9×	2.4k 0.9×	509 0.3×	2.0k 1.4×	147	9.7k

Countries citing papers authored by Eijiro Jimi

Since Specialization

Citations

This map shows the geographic impact of Eijiro Jimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eijiro Jimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eijiro Jimi more than expected).

Fields of papers citing papers by Eijiro Jimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eijiro Jimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eijiro Jimi. The network helps show where Eijiro Jimi may publish in the future.

Co-authorship network of co-authors of Eijiro Jimi

This figure shows the co-authorship network connecting the top 25 collaborators of Eijiro Jimi. A scholar is included among the top collaborators of Eijiro Jimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eijiro Jimi. Eijiro Jimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hayashi, Yoshikazu, Shohei Yoshimoto, Atsushi Yasukochi, et al.. (2025). 4-Octyl Itaconate Attenuates Cell Proliferation by Cellular Senescence via Glutathione Metabolism Disorders and Mitochondrial Dysfunction in Melanoma. Antioxidants and Redox Signaling. 42(10-12). 547–565. 2 indexed citations

Nakagawa, Takayuki, Shigehiro Ono, Kei Tobiume, et al.. (2025). Anticancer effect of the antirheumatic drug leflunomide on oral squamous cell carcinoma by the inhibition of tumor angiogenesis. Discover Oncology. 16(1). 53–53.

Gao, Jing, Fei Huang, Miho Matsuda, et al.. (2024). Phosphorylation of Serine 536 of p65(RelA) Downregulates Inflammatory Responses. Inflammation. 48(3). 1499–1512. 1 indexed citations

Tsukamoto, Sho, et al.. (2023). Wnt7b expressed by hypertrophic chondrocytes is a stimulatory factor for endochondral ossification that is regulated by Smad4 activity. Development. 150(15). 3 indexed citations

Yang, Nan, et al.. (2023). Inhibition of non-canonical NF-κB signaling suppresses periodontal inflammation and bone loss. Frontiers in Immunology. 14. 1179007–1179007. 11 indexed citations

Kawabata, Yuko, Shingo Takai, Keisuke Sanematsu, et al.. (2023). The G protein‐coupled receptor GPRC5C is a saccharide sensor with a novel ‘off’ response. FEBS Letters. 597(15). 2006–2016. 2 indexed citations

Nakatomi, Chihiro, Mitsushiro Nakatomi, Takuma Matsubara, et al.. (2019). Constitutive activation of the alternative NF-κB pathway disturbs endochondral ossification. Bone. 121. 29–41. 16 indexed citations

Okamoto, K., et al.. (2016). The Novel NF‐κB Inhibitor, MTI‐II Peptide Anti‐Inflammatory Drug, Suppresses Inflammatory Responses in Odontoblast‐Like Cells. Journal of Cellular Biochemistry. 117(11). 2552–2558. 9 indexed citations

Furuta, Hiroyuki, Kenji Osawa, Masashi Shin, et al.. (2012). Selective inhibition of NF‐κB suppresses bone invasion by oral squamous cell carcinoma in vivo. International Journal of Cancer. 131(5). E625–35. 30 indexed citations

10.

Nakamura, Ichiro, Naoyuki Takahashi, Eijiro Jimi, Nobuyuki Udagawa, & Tatsuo Suda. (2011). Regulation of osteoclast function. Modern Rheumatology. 22(2). 167–177. 66 indexed citations

11.

Jimi, Eijiro, et al.. (2010). Basic Approaches for Bone Regeneration. The Journal of the Kyushu Dental Society. 64(3). 74–83. 1 indexed citations

12.

Jimi, Eijiro, Hiroyuki Furuta, Keitaro Matsuo, et al.. (2010). The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma. Oral Diseases. 17(5). 462–468. 80 indexed citations

13.

Soysa, Niroshani S., Neil Alles, Debra Weih, et al.. (2009). The pivotal role of the alternative NF-κB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. Journal of Bone and Mineral Research. 25(4). 809–818. 62 indexed citations

14.

Yamazaki, Masato, Hidefumi Fukushima, Masashi Shin, et al.. (2009). Tumor Necrosis Factor α Represses Bone Morphogenetic Protein (BMP) Signaling by Interfering with the DNA Binding of Smads through the Activation of NF-κB. Journal of Biological Chemistry. 284(51). 35987–35995. 112 indexed citations

15.

Zhang, Zhiyuan, Eijiro Jimi, & Alfred L.M. Bothwell. (2003). Receptor Activator of NF-κB Ligand Stimulates Recruitment of SHP-1 to the Complex Containing TNFR-Associated Factor 6 That Regulates Osteoclastogenesis. The Journal of Immunology. 171(7). 3620–3626. 59 indexed citations

16.

Nakamura, Ichiro, Yuho Kadono, Hiroshi Takayanagi, et al.. (2002). IL-1 Regulates Cytoskeletal Organization in Osteoclasts Via TNF Receptor-Associated Factor 6/c-Src Complex. The Journal of Immunology. 168(10). 5103–5109. 55 indexed citations

17.

Zhong, Haihong, Michael J. May, Eijiro Jimi, & Sankar Ghosh. (2002). The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1. Molecular Cell. 9(3). 625–636. 803 indexed citations breakdown →

18.

Voll, Reinhard, Eijiro Jimi, Domingo F. Barber, et al.. (2000). NF-κB Activation by the Pre-T Cell Receptor Serves as a Selective Survival Signal in T Lymphocyte Development. Immunity. 13(5). 677–689. 242 indexed citations

19.

Udagawa, Nobuyuki, N. Takahashi, Eijiro Jimi, et al.. (1999). Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone. 25(5). 517–523. 358 indexed citations

20.

Nakamura, Ichiro, Naoyuki Takahashi, Nobuyuki Udagawa, et al.. (1997). Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice. FEBS Letters. 401(2-3). 207–212. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact